Objective: To evaluate the role of newer agents in the management of atrial fibrillation (AF ... over warfarin at no to minimal cost. Each new anticoagulant lacks a reversal agent and an assay ...

Although initial data for both dronedarone and dabigatran seemed to establish a role for these therapies, more recent data have raised questions about the safety of these drugs. While the data for ...

Johnson & Johnson’s JNJ MedTech unit has temporarily paused sales of Varipulse, its pulsed field ablation (PFA) therapy to ...

In that single-arm study, the rate of primary adverse events within 7 days of ablation was 2.9%, with the most common ...

Pulsed field ablation (PFA) is emerging as an alternative, using non-thermal electric fields to target cardiac tissue while ...

About 200,000 Louisiana residents are living with a heart condition called atrial fibrillation but there is a new treatment ...

In a new review article scientists summarize the current evidence regarding the epidemiology, pathophysiology, diagnosis and management of AF. In the U.S., atrial fibrillation (AF), a heart ...